O
THRX
OrbiMed’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-17,713,600
| Closed | -$71.7M | – | 130 |
|
|
2023
Q4 | $71.7M | Hold |
17,713,600
| – | – | 1.43% | 24 |
|
|
2023
Q3 | $47.6M | Buy |
17,713,600
+479,932
| +3% | +$1.29M | 1.01% | 36 |
|
|
2023
Q2 | $161M | Hold |
17,233,668
| – | – | 2.91% | 5 |
|
|
2023
Q1 | $153M | Hold |
17,233,668
| – | – | 3% | 8 |
|
|
2022
Q4 | $85.8M | Buy |
17,233,668
+192,000
| +1% | +$956K | 1.64% | 16 |
|
|
2022
Q3 | $98.8K | Hold |
17,041,668
| – | – | 1.83% | 19 |
|
|
2022
Q2 | $94.2K | Hold |
17,041,668
| – | – | 1.71% | 22 |
|
|
2022
Q1 | $196M | Buy |
17,041,668
+203,000
| +1% | +$2.34M | 3.19% | 5 |
|
|
2021
Q4 | $214M | Buy |
+16,838,668
| New | +$214M | 2.74% | 5 |
|